CXCL2 mediates lipopolysaccharide-induced osteoclastogenesis in RANKL-primed precursors

Cytokine

Volumn 55, Issue 1, 2011, Pages 48-55

  Ha, Jeongim ^a   Lee, Youngkyun ^a   Kim, Hong Hee ^a  

^a Seoul National University   (South Korea)

Author keywords

CXCL2; Inflammation; LPS; Migration; Osteoclastogenesis

Indexed keywords

BETA INTERFERON; CXCL2 CHEMOKINE; CXCL2 NEUTRALIZING ANTIBODY; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; NEUTRALIZING ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN C FOS; REACTIVE OXYGEN METABOLITE; REPARIXIN; SYNAPTOPHYSIN; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; BONE MARROW CELL; BONE MARROW MACROPHAGE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG MECHANISM; MACROPHAGE; MALE; MOUSE; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW CELLS; BONE RESORPTION; CELL MOVEMENT; CHEMOKINE CXCL2; GENE EXPRESSION REGULATION; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED ICR; NEUTRALIZATION TESTS; NF-KAPPA B; OSTEOCLASTS; OSTEOGENESIS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; RANK LIGAND;

MUS;

EID: 79956342694     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.03.026     Document Type: Article

References (39)

1. Boyle W.J., Simonet W.S., Lacey D.L. Osteoclast differentiation and activation. Nature 2003, 423:337-342.
2. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998, 93:165-176.
3. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Mochizuki S., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998, 95:3597-3602.
4. Roodman G.D. Regulation of osteoclast differentiation. Ann NY Acad Sci 2006, 1068:100-109.
5. Nakamura I., Rodan G.A., Duong le T. Regulatory mechanism of osteoclast activation. J Electron Microsc (Tokyo) 2003, 52:527-533.
6. Teitelbaum S.L. Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res Ther 2006, 8:201.
7. Nair S.P., Meghji S., Wilson M., Reddi K., White P., Henderson B. Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun 1996, 64:2371-2380.
8. Ozaki Y., Ukai T., Yamaguchi M., Yokoyama M., Haro E.R., Yoshimoto M., et al. Locally administered T cells from mice immunized with lipopolysaccharide (LPS) accelerate LPS-induced bone resorption. Bone 2009, 44:1169-1176.
9. Zhuang L., Jung J.Y., Wang E.W., Houlihan P., Ramos L., Pashia M., et al. Pseudomonas aeruginosa lipopolysaccharide induces osteoclastogenesis through a toll-like receptor 4 mediated pathway in vitro and in vivo. Laryngoscope 2007, 117:841-847.
10. Zou W., Bar-Shavit Z. Dual modulation of osteoclast differentiation by lipopolysaccharide. J Bone Miner Res 2002, 17:1211-1218.
11. Wolpe S.D., Cerami A. Macrophage inflammatory proteins 1 and 2: members of a novel superfamily of cytokines. FASEB J 1989, 3:2565-2573.
12. Zhou H., Andonegui G., Wong C.H., Kubes P. Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation. J Immunol 2009, 183:5244-5250.
13. Roche J.K., Keepers T.R., Gross L.K., Seaner R.M., Obrig T.G. CXCL1/KC and CXCL2/MIP-2 are critical effectors and potential targets for therapy of Escherichia coli O157:H7-associated renal inflammation. Am J Pathol 2007, 170:526-537.
14. De Plaen I.G., Han X.B., Liu X., Hsueh W., Ghosh S., May M.J. Lipopolysaccharide induces CXCL2/macrophage inflammatory protein-2 gene expression in enterocytes via NF-kappaB activation: independence from endogenous TNF-alpha and platelet-activating factor. Immunology 2006, 118:153-163.
15. Han X.B., Liu X., Hsueh W., De Plaen I.G. Macrophage inflammatory protein-2 mediates the bowel injury induced by platelet-activating factor. Am J Physiol Gastrointest Liver Physiol 2004, 287:G1220-1226.
16. Reutershan J., Morris M.A., Burcin T.L., Smith D.F., Chang D., Saprito M.S., et al. Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J Clin Invest 2006, 116:695-702.
17. Ha J., Choi H.S., Lee Y., Kwon H.J., Song Y.W., Kim H.H. CXC chemokine ligand 2 induced by receptor activator of NF-kappaB ligand enhances osteoclastogenesis. J Immunol 2010, 184:4717-4724.
18. Ha J., Choi H.S., Lee Y., Lee Z.H., Kim H.H. Caffeic acid phenethyl ester inhibits osteoclastogenesis by suppressing NF kappaB and downregulating NFATc1 and c-Fos. Int Immunopharmacol 2009, 9:774-780.
19. Kim D.S., Han J.H., Kwon H.J. NF-kappaB and c-Jun-dependent regulation of macrophage inflammatory protein-2 gene expression in response to lipopolysaccharide in RAW 264.7 cells. Mol Immunol 2003, 40:633-643.
20. Huang H., Park C.K., Ryu J.Y., Chang E.J., Lee Y., Kang S.S., et al. Expression profiling of lipopolysaccharide target genes in RAW264.7 cells by oligonucleotide microarray analyses. Arch Pharm Res 2006, 29:890-897.
21. Fujihara M., Ito N., Pace J.L., Watanabe Y., Russell S.W., Suzuki T. Role of endogenous interferon-beta in lipopolysaccharide-triggered activation of the inducible nitric-oxide synthase gene in a mouse macrophage cell line, J774. J Biol Chem 1994, 269:12773-12778.
22. Kim D., Kim J., Kwon S., Kim Y.J., Lee S., Lee Y., et al. Regulation of macrophage inflammatory protein-2 gene expression in response to 2,4-dinitrofluorobenzene in RAW 264.7 cells. BMB Rep 2008, 41:316-321.
23. Takayanagi H., Ogasawara K., Hida S., Chiba T., Murata S., Sato K., et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 2006, 408:600-605.
24. Chang E.J., Ha J., Oerlemans F., Lee Y.J., Lee S.W., Ryu J., et al. Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption. Nat Med 2008, 14:966-972.
25. Blatteis C.M., Li S., Li Z., Perlik V., Feleder C. Signaling the brain in systemic inflammation: the role of complement. Front Biosci 2004, 9:915-931.
26. Tsutsui H., Matsui K., Okamura H., Nakanishi K. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev 2000, 174:192-209.
27. Escalante B.A., McGiff I.C., Ferreri N.R. The renal medullary thick ascending limb as a model for understanding lipid mediators in sepsis. J Physiol Pharmacol 1997, 48:507-515.
28. Togbe D., Schnyder-Candrian S., Schnyder B., Doz E., Noulin N., Janot L., et al. Toll-like receptor and tumour necrosis factor dependent endotoxin-induced acute lung injury. Int J Exp Pathol 2007, 88:387-391.
29. Feldman A.M., Combes A., Wagner D., Kadakomi T., Kubota T., Li Y.Y., et al. The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 2000, 35:537-544.
30. Hickson-Bick D.L., Jones C., Buja L.M. The response of neonatal rat ventricular myocytes to lipopolysaccharide-induced stress. Shock 2006, 25:546-552.
31. Findlay D.M., Haynes D.R. Mechanisms of bone loss in rheumatoid arthritis. Mod Rheumatol 2005, 15:232-240.
32. Cochran D.L. Inflammation and bone loss in periodontal disease. J Periodontol 2008, 79:1569-1576.
33. Koide M., Kinugawa S., Takahashi N., Udagawa N. Osteoclastic bone resorption induced by innate immune responses. Periodontol 2000 2010, 54:235-246.
34. Suda K., Udagawa N., Sato N., Takami M., Itoh K., Woo J.T., et al. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation. J Immunol 2004, 172:2504-2510.
35. Wiesel P., Patel A.P., DiFonzo N., Marria P.B., Sim C.U., Pellacani A., et al. Endotoxin-induced mortality is related to increased oxidative stress and end-organ dysfunction, not refractory hypotension, in heme oxygenase-1-deficient mice. Circulation 2000, 102:3015-3022.
36. Keating D.J. Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases. J Neurochem 2008, 104:298-305.
37. Ing J.L., Soll D. Severe oxidative stress induces protein mistranslation through impairment of an aminoacyl-tRNA synthetase editing site. Proc Natl Acad Sci USA 2010, 107:4028-4033.
38. Pelus L.M., Horowitz D., Cooper S.C., King A.G. Peripheral blood stem cell mobilization. A role for CXC chemokines. Crit Rev Oncol Hematol 2002, 43:257-275.
39. Coelho F.M., Pinho V., Amaral F.A., Sachs D., Costa V.V., Rodrigues D.H., et al. The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature. Arthritis Rheum 2008, 58:2329-2337.